Chromosomal amplification of leucine-rich repeat kinase-2 (LRRK2) is required for oncogenic MET signaling in papillary renal and thyroid carcinomas.

Source:http://linkedlifedata.com/resource/pubmed/id/21220347

Proc. Natl. Acad. Sci. U.S.A. 2011 Jan 25 108 4 1439-44

Download in:

View as

Triples

General Info

PMID
21220347